Bringing What We Learned at the Virtual ERS Conference Into Practice
Listen to experts report on current publications, posters, and sessions from a recent pulmonology conference. Faculty discuss the latest on Systemic sclerosis ILD and Progressive fibrosing ILD and discuss the implication of this information on current clinical practices for clinicians.
Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
SSc-ILD: Progress in Diagnosis and Treatment
Launched: September 25, 2020
SSc-ILD: Anti-acid Therapy Treatment
Launched: September 25, 2020
Updates on Mono and Combination Therapy
Launched: September 25, 2020
Real-world Long-term Experience with Antifibrotic Treatment
Launched: September 25, 2020
PF-ILD: Prevalence, Genetics, and Mortality
Launched: September 25, 2020
New Prospects for Diagnosis and Prognosis
Launched: September 25, 2020
PF-ILD: Treatment Efficacy Based on PF-ILD Subtype and Concomitant Treatment with RA Medication
Launched: September 25, 2020
PF-ILD: Treatment Efficacy Based on Disease Severity and with Progressive Phenotype
Launched: September 25, 2020
